Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02410980 · ClinicalTrials.gov registry record · Early Phase 1
Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies
A Early Phase 1 study of Collagen Fibril Alteration, sponsored by University of California, Irvine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02410980 is a Early Phase 1 study of Collagen Fibril Alteration that has completed, run by University of California, Irvine. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02410980, a Early Phase 1 study of Collagen Fibril Alteration, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers will assess the effects of treatment with tretinoin cream on human skin by using non-invasive optical imaging technologies.
Conditions Studied
Interventions
- DRUG Tretinoin cream 0.1%
Study Locations (1)
California
- Beckman Laser Institute Medical Clinic - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02410980
The ClinicalTrials.gov registry entry for NCT02410980 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Collagen Fibril Alteration appearing as the primary indexed condition, and to 1 intervention - of which Tretinoin cream 0.1% is the first listed.
NCT02410980 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02410980 about?
NCT02410980 is a clinical study titled "Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies". The researchers will assess the effects of treatment with tretinoin cream on human skin by using non-invasive optical imaging technologies.
What is the current status of trial NCT02410980?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2015-08. Estimated completion is 2016-12.
What conditions does trial NCT02410980 study?
This clinical trial studies the following conditions: Collagen Fibril Alteration.
What interventions are being tested in trial NCT02410980?
The interventions under investigation include: Tretinoin cream 0.1% (DRUG).
Who is sponsoring clinical trial NCT02410980?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02410980 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.